Effect of tomato juice consumption on blood antioxidative biomarkers

The requested reference [375b090a9fa2f4daf354f49bd11c1a3d84ee315f] no longer exists in our database. It has been replaced by the current reference: [f38741028806983282ed2284238822986cd3d57d]

Authors
Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2014
INTERVENTION: control group: 330 ml/d for 20 days, 110 ml with their main meal (three times a day) Intervention 1: intervention group: 330 ml/d tomato juice for 20 days, 110 ml with their main meal (three times a day). Intervention 2: control group: 330 ml/d for 20 days, 110 ml with their main meal (three times a day). intervention group: 330 ml/d tomato juice for 20 days, 110 ml with their main meal (three times a day) Prevention CONDITION: ???? ???? ?? ????? ????? Condition 1: overweight. Condition 2: obese. ; Simple obesity NOS ; ???? ???? ?? ????? ????? Simple obesity NOS PRIMARY OUTCOME: Catalase. Timepoint: befor the intervention and 20 days after that. Method of measurement: in erythrocytes by spectrophotometric method according to U/gHb. Glutathione peroxidase. Timepoint: befor the intervention and 20 days after that. Method of measurement: in erythrocytes using hydrogen peroxide according to U/gHb. Malondialdehyde. Timepoint: befor the intervention and 20 days after that. Method of measurement: in serum according to µmol/ml. Superoxide dismutase. Timepoint: befor the intervention and 20 days after that. Method of measurement: in erythrocytes enzymatic method according to U/gHb. Total antioxidant capacity. Timepoint: befor the intervention and 20 days after that. Method of measurement: in plasma by spectrophotometric method according to mg/dl. INCLUSION CRITERIA: INCLUSION CRITERIA: female, age between 20 and 30 years. Exclusion criteria: having any inflammatory diseases, including diabetes, CVD, multiple sclerosis, rheumatoid arthritis, cancers, asthma and allergies. Intake of any medication or vitamin/mineral supplement or any tobacco products
Epistemonikos ID: a145dfabcb348b6c905d6621598e6d5934b4ee7a
First added on: Mar 24, 2022